Ergoteles LLC Insmed Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$16.26 - $21.73 $1.26 Million - $1.68 Million	77,184 New	77,184 $1.32 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.92 Million - $2.6 Million	91,996 Added 397.82%	115,121 $2.48 Million
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $166,210 - $250,338	-9,737 Reduced 29.63%	23,125 $456,000
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $671,042 - $924,408	32,862 New	32,862 $772,000
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $181,926 - $238,707	-8,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$24.17 - $36.01 $195,777 - $291,681	8,100 New	8,100 $231,000

478

180M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.